BRCA1 modulates the expression of hnRNPA2B1 and KHSRP

Cell Cycle

Volumn 9, Issue 23, 2010, Pages 4666-4673

  Santarosa, Manuela ^a   Del Col, Laura ^a   Viel, Alessandra ^a   Bivi, Nicoletta ^b   D'Ambrosio, Chiara ^c   Scaloni, Andrea ^c   Tell, Gianluca ^b   Maestro, Roberta ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c CNR   (Italy)

Author keywords

BRCA1; hnRNPA2B1; KHSRP; Proteomics; RNA metabolism

Indexed keywords

BRCA1 PROTEIN; COMPLEMENTARY DNA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2 B1; KH TYPE SPLICING REGULATORY PROTEIN; MICRORNA; POLYPEPTIDE; REGULATOR PROTEIN; RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA REPAIR; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDE ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA METABOLISM; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 78650157692     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.23.14022     Document Type: Article

References (40)

1. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000; 92:564-9; PMID: 10749912; DOI:10.1093/jnci/92.7.564.
2. Wei M, Xu J, Dignam J, Nanda R, Sveen L, Fackenthal J, et al. Estrogen receptor alpha, BRCA1 and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers. Breast Cancer Res Treat 2008; 111:113-20; PMID: 17932744; DOI:10.1007/s10549-007-9766-6.
3. Huen MS, Sy SM, Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 2010; 11:138-48; PMID: 20029420; DOI: 10.1038/nrm2831.
4. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000; 14:927-39; PMID: 10783165. (Pubitemid 30253002)
5. Santarosa M, Del Col L, Tonin E, Caragnano A, Viel A, Maestro R. Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers. Mol Cancer Ther 2009; 8:844-54; PMID: 19372557; DOI:10.1158/1535-7163. MCT-08-0951.
6. Dreyfuss G, Kim VN, Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 2002; 3:195-205; PMID: 11994740; DOI:10.1038/nrm760.
7. Gherzi R, Trabucchi M, Ponassi M, Ruggiero T, Corte G, Moroni C, et al. The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol 2006; 5:5; PMID: 17177604; DOI: 10.1371/journal.pbio.0050005.
8. Quinn JE, Kennedy RD, Mullan PB, Gilmore PM, Carty M, Johnston PG, et al. BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. Cancer Res 2003; 63:6221-8; PMID: 14559807; DOI:10.1016/S1359-6349(04)80219-2.
9. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004; 6:1-6; PMID: 15068665.
10. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415:530-6; PMID: 11823860; DOI: 10.1038/415530a.
11. Pawitan Y, Bjöhle J, Amler L, Borg AL, Egyhazi S, Hall P, et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res 2005; 7:953-64; PMID: 16280042; DOI: 10.1186/bcr1325.
12. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001; 344:539-48; PMID: 11207349; DOI: 10.1056/NEJM200102223440801.
13. Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET. Gene expression profiles of BRCA1-linked, BRCA2-linked and sporadic ovarian cancers. J Natl Cancer Inst 2002; 94:990-1000; PubMed PMID: 12096084. (Pubitemid 34814728)
14. Boulton SJ. BRCA1-mediated ubiquitylation. Cell Cycle 2006; 5:1481-6; PMID: 16861894.
15. Aiyar S, Sun JL, Li R. BRCA1: a locus-specific "liaison" in gene expression and genetic integrity. J Cell Biochem 2005; 94:1103-11; PMID: 15723343; DOI: 10.1002/jcb.20386.
16. Scully R, Anderson SF, Chao DM, Wei W, Ye L, Young RA, et al. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 1997; 94:5605-10; PMID: 9159119.
17. Anderson SF, Schlegel BP, Nakajima T, Wolpin ES, Parvin JD. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat Genet 1998; 19:254-6; PMID: 9662397; DOI: 10.1038/930. (Pubitemid 28309336)
18. Krum SA, Miranda GA, Lin C, Lane TF. BRCA1 associates with processive RNA polymerase II. J Biol Chem 2003; 278:52012-20; PMID: 14506230; DOI: 10.1074/jbc.M308418200.
19. Guil S, Cáceres JF. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol 2007; 14:591-6; PMID: 17558416; DOI: 10.1038/nsmb1250. (Pubitemid 47037061)
20. Zhou J, Allred DC, Avis I, Martínez A, Vos MD, Smith L, et al. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat 2001; 66:217-24; PMID: 11510693.
21. Moran-Jones K, Grindlay J, Jones M, Smith R, Norman JC. hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration. Cancer Res 2009; 69:9219-27; PMID: 19934309; DOI: 10.1158/0008-5472.CAN-09-1852.
22. Carpenter B, MacKay C, Alnabulsi A, MacKay M, Telfer C, Melvin WT, et al. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 2006; 1765:85-100; PMID: 16378690; DOI: 10.1016/j.bbcan.2005.10.002.
23. Tauler J, Zudaire E, Liu H, Shih J, Mulshine JL. hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines. Cancer Res 2010; 70:7137-47. PMID: 20807810; DOI: 10.1158/0008-5472.CAN-10-0860.
24. Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R, et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010; 7:403-17; PMID: 20804975; DOI: 10.1016/j.stem.2010.07.010.
25. Liu X, Holstege H, van der Gulden H, Treur-Mulder M, Zevenhoven J, Velds A, et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc Natl Acad Sci USA 2007; 104:12111-6; PMID: 17626182; DOI: 10.1073/pnas.0702969104.
26. Morozumi Y, Takizawa Y, Takaku M, Kurumizaka H. Human PSF binds to RAD51 and modulates its homologous-pairing and strand-exchange activities. Nucleic Acids Res 2009; 37:4296-307; PMID: 19447914; DOI: 10.1093/nar/gkp298.
27. Tell G, Wilson DM, 3rd, Lee CH. Intrusion of a DNA repair protein in the RNome world: is this the beginning of a new era? Mol Cell Biol 2010; 30:366-71; PMID: 19901076; DOI: 10.1128/MCB.01174-09.
28. Iwanaga K, Sueoka N, Sato A, Hayashi S, Sueoka E. Heterogeneous nuclear ribonucleoprotein B1 protein impairs DNA repair mediated through the inhibition of DNA-dependent protein kinase activity. Biochem Biophys Res Commun 2005; 333:888-95; PMID: 15964549; DOI 10.1016/j.bbrc.2005.05.180. (Pubitemid 40854242)
29. Briata P, Forcales SV, Ponassi M, Corte G, Chen CY, Karin M, et al. p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell 2005; 20:891-903; PMID: 16364914; DOI: 10.1016/j.molcel. 2005.10.021. (Pubitemid 41814878)
30. Seok H, Cho J, Cheon M, Park IS. Biochemical characterization of apoptotic cleavage of KH-type splicing regulatory protein (KSRP)/far upstream element-binding protein 2 (FBP2). Protein Pept Lett 2002; 9:511-9; PMID: 12553859.
31. Zubaidah RM, Tan GS, Tan SB, Lim SG, Lin Q, Chung MC. 2-D DIGE profiling of hepatocellular carcinoma tissues identified isoforms of far upstream binding protein (FUBP) as novel candidates in liver carcinogenesis. Proteomics 2008; 8:5086-96; PMID: 19003864; DOI: 10.1002/pmic.200800322.
32. Bakheet T, Frevel M, Williams BR, Greer W, Khabar KS. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 2001; 29:246-54; PMID: 11125104.
33. Trabucchi M, Briata P, Garcia-Mayoral M, Haase AD, Filipowicz W, Ramos A, et al. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009; 459:1010-4; PMID: 19458619; DOI: 10.1038/nature08025.
34. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008; 14:2348-60; PMID: 18812439; DOI: 10.1261/rna.1034808.
35. Qian B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, et al. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat 2009; 117:131-40; PMID: 18932017; DOI: 10.1007/s10549-008-0219-7.
36. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065-70; PMID: 16103053; DOI: 10.1158/0008-5472.CAN-05-1783.
37. Guttilla IK, White BA. Coordinate regulation of FOXO1 by miR-27a, miR-96 and miR-182 in breast cancer cells. J Biol Chem 2009; 284:23204-16; PMID: 19574223; DOI: 10.1074/jbc.M109.031427.
38. Thiede B, Dimmler C, Siejak F, Rudel T. Predominant identification of RNA-binding proteins in Fas-induced apoptosis by proteome analysis. J Biol Chem 2001; 276:26044-50; PMID: 11352910; DOI:10.1074/jbc.M101062200.
39. Bivi N, Bereszczak JZ, Romanello M, Zeef LA, Delneri D, Quadrifoglio F, et al. Transcriptome and proteome analysis of osteocytes treated with nitrogen-containing bisphosphonates. J Proteome Res 2009; 8:1131-42; PMID: 19226166; DOI:10.1021/pr8005606.
40. Talamo F, D'Ambrosio C, Arena S, Del Vecchio P, Ledda L, Zehender G, et al. Proteins from bovine tissues and biological fluids: defining a reference electrophoresis map for liver, kidney, muscle, plasma and red blood cells. Proteomics 2003; 3:440-60; PMID: 12687612; DOI:10.1002/pmic.200390059. (Pubitemid 36428297)